What does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL?

MOspace/Manakin Repository

Breadcrumbs Navigation

What does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL?

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/4005

[-] show simple item record

dc.contributor.author Nelson, Carrie
dc.contributor.author Hitchcock, Kristin
dc.contributor.author Bohlen, James A.
dc.date.accessioned 2009-12-17T19:48:27Z
dc.date.available 2009-12-17T19:48:27Z
dc.date.issued 2009-12 en
dc.identifier.citation Journal of Family Practice, 58(12) 2009: 665-667. en
dc.identifier.uri http://hdl.handle.net/10355/4005
dc.description.abstract No studies directly compare low-density lipoprotein (LDL) levels <70 mg/dL to levels of 71 to 100 mg/dL in very-high-risk patients. However, no evidence suggests a “floor” for LDL cholesterol levels beyond which further reductions of heart disease risk can't be achieved (strength of recommendation [SOR]: A, systematic reviews of randomized controlled trials [RCTs]). The target LDL cholesterol of <70 mg/dL is based on data extrapolated from RCTs (SOR: B). en
dc.language.iso en_US en
dc.publisher Family Physicians Inquiries Network en
dc.relation.ispartof Clinical Inquiries, 2009 (MU) en
dc.subject coronary artery disease en
dc.subject statin therapy en
dc.subject cholesterol en
dc.subject.lcsh Coronary heart disease -- Prevention en
dc.subject.lcsh Low density lipoproteins en
dc.subject.lcsh Statins (Cardiovascular agents) -- Effectiveness en
dc.title What does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL? en
dc.type Article en
dc.relation.ispartofcommunity University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network


This item appears in the following Collection(s)

[-] show simple item record